Barriers to recruiting underrepresented populations to cancer clinical trials: A systematic review

Racial and ethnic minorities, older adults, rural residents, and individuals of low socioeconomic status are underrepresented among participants in cancer‐related trials. The authors conducted a systematic review to determine the barriers to participation of underrepresented populations in cancer‐related trials. Their search included English‐language publications that reported original data on the recruitment of underrepresented groups to cancer treatment or prevention trials between 1966 and December 2005 in multiple electronic databases. They also hand‐searched titles in 34 journals from January 2003 to December 2005 and they examined reference lists for eligible articles. Titles and abstracts were reviewed to identify relevant studies. Data on barriers to participation were synthesized both qualitatively and based on statistically significant associations with trial enrollment. Of 5257 studies that were cited, 65 studies were eligible for inclusion in the current analysis, including 46 studies on recruitment into cancer therapeutic trials, 15 studies on recruitment into prevention trials, and 4 studies on recruitment into both prevention and treatment trials. Numerous factors were reported as barriers to participation in cancer‐related trials. However, only 20 of the studies reported statistically significant associations between hypothesized barriers and enrollment. The available evidence had limitations in quality regarding representativeness, justification of study methods, the reliability and validity of data‐collection methods, potential for bias, and data analysis. The results indicated that underrepresented populations face numerous barriers to participation in cancer‐related trials. The current systematic review highlighting the literature on recruitment of underrepresented populations to cancer trials and may be used as the evidence base toward developing an agenda for etiologic and intervention research to reduce the disparities in participation in cancer‐related trials. Cancer 2008. © 2007 American Cancer Society.

[1]  I. Thompson,et al.  Minority recruitment in the prostate cancer prevention trial. , 2000, Annals of epidemiology.

[2]  C. Gross,et al.  Enrollment of older persons in cancer trials after the medicare reimbursement policy change. , 2005, Archives of internal medicine.

[3]  C. Gross,et al.  The impact of socioeconomic status and race on trial participation for older women with breast cancer , 2005, Cancer.

[4]  C. Gross,et al.  Enrolling older persons in cancer trials: the effect of sociodemographic, protocol, and recruitment center characteristics. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  H. Freeman,et al.  The impact of clinical trial protocols on patient care systems in a large city hospital access for the socially disadvantaged , 1993, Cancer.

[6]  A. Ziogas,et al.  Recruitment strategies for cervical cancer prevention study. , 2002, Gynecologic oncology.

[7]  B. Fisher.  On clinical trial participation. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Sarah M. Greene,et al.  Organizational barriers to physician participation in cancer clinical trials. , 2005, The American journal of managed care.

[9]  Colin B Begg,et al.  Survival of blacks and whites after a cancer diagnosis. , 2002, JAMA.

[10]  Moon S. Chen,et al.  Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Suzanne W. Churchill,et al.  Minority recruitment in clinical trials: a conference at Tuskegee, researchers and the community. , 2000, Annals of epidemiology.

[12]  J. Young,et al.  Entry into clinical trials in breast cancer: the importance of specialist teams. Scottish Breast Cancer Focus Group and Scottish Cancer Therapy Network. , 1998, European journal of cancer.

[13]  S. B. Robinson,et al.  Attitudes of African-Americans regarding prostate cancer clinical trials , 1996 .

[14]  J. Hardy,et al.  What influences participation in clinical trials in palliative care in a cancer centre? , 2000, European journal of cancer.

[15]  A. Shad,et al.  Identifying, recruiting, and enrolling adolescent survivors of childhood cancer into a randomized controlled trial of health promotion: preliminary experiences in the Survivor Health and Resilience Education (SHARE) Program. , 2006, Journal of pediatric psychology.

[16]  Harlan M Krumholz,et al.  Participation in cancer clinical trials: race-, sex-, and age-based disparities. , 2004, JAMA.

[17]  M. Christian,et al.  How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  N. Powe,et al.  Effectiveness of strategies to recruit underrepresented populations into cancer clinical trials , 2006, Clinical trials.

[19]  M. Ruffin,et al.  Recruitment and retention of economically underserved women to a cervical cancer prevention trial. , 2004, Applied nursing research : ANR.

[20]  L. Finison,et al.  Medical oncologists' participation in cancer clinical trials. , 1984, Progress in clinical and biological research.

[21]  E. Perez,et al.  Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  A. Kaluzny,et al.  Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program. , 1993, Journal of the National Cancer Institute.

[23]  M. Fouad,et al.  Recruitment and retention of minority women in cancer screening, prevention, and treatment trials. , 2000, Annals of epidemiology.

[24]  P. Ganz,et al.  Recruitment and retention challenges in breast cancer survivorship research: results from a multisite, randomized intervention trial in women with early stage breast cancer. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[25]  C DeShazer,et al.  Racial differences in the treatment of early-stage lung cancer. , 2000, The New England journal of medicine.

[26]  M. Broome,et al.  The Influence of Relationships on Children’s and Adolescents’ Participation in Research , 2003, Nursing research.

[27]  S. Millon-Underwood.  Determinants of participation in state‐of‐the‐art cancer prevention, early detection/screening, and treatment trials among African‐Americans , 1993, Cancer nursing.

[28]  M. Moser,et al.  Responses to captopril and hydrochlorothiazide in black patients with hypertension , 1982, Clinical pharmacology and therapeutics.

[29]  N. L. Roberson.  Clinical trial participation: Viewpoints from racial/ethnic groups , 1994, Cancer.

[30]  C. Gross,et al.  Impact of managed care on cancer trial enrollment. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  H. Rugo,et al.  Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers. , 2005, Clinical breast cancer.

[32]  B. Rimer,et al.  Recruiting high risk women into a breast cancer health promotion trial. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[33]  M. Topçu,et al.  Willingness to participate in clinical treatment research among older African Americans and Whites. , 2003, The Gerontologist.

[34]  V. Shavers,et al.  Racial and ethnic disparities in the receipt of cancer treatment. , 2002, Journal of the National Cancer Institute.

[35]  J. Bailar,et al.  Selection and description of cancer clinical trials participants—Science or happenstance? , 2002, Cancer.

[36]  G. Omenn,et al.  Participation and adherence among older men and women recruited to the Beta-Carotene and Retinol Efficacy trial (CARET). , 1991, The Gerontologist.

[37]  Christine I. Chen,et al.  A Comparison of Elderly Patients with Aggressive Histology Lymphoma who Were Entered or Not Entered on to a Randomized Phase II Trial , 2000, Leukemia & lymphoma.

[38]  T. Ricketts,et al.  Clinical trial enrollment of rural patients with cancer. , 2002, Cancer practice.

[39]  M. Ruffin,et al.  Original ArticlesWomen's feedback on a chemopreventive trial for cervical dysplasia*** , 2003 .

[40]  Giselle Corbie-Smith,et al.  Attitudes and beliefs of african americans toward participation in medical research , 1999, Journal of General Internal Medicine.

[41]  B. Howard,et al.  Special populations recruitment for the Women's Health Initiative: successes and limitations. , 2004, Controlled clinical trials.

[42]  R. Yancik,et al.  Selection factors in clinical trials: results from the Community Clinical Oncology Program Physician's Patient Log. , 1987, Cancer treatment reports.

[43]  J. Mandelblatt,et al.  Breast cancer prevention in community clinics: will low-income Latina patients participate in clinical trials? , 2005, Preventive medicine.

[44]  S. Havstad,et al.  A randomized trial of recruitment methods for older African American men in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial , 2004, Clinical trials.

[45]  B. Berman,et al.  Recruitment to a school-based adult smoking-cessation program: do gender and race/ethnicity make a difference? , 1998, Journal of cancer education : the official journal of the American Association for Cancer Education.

[46]  Robert C. Gooding,et al.  Enrollment of African Americans onto clinical treatment trials: study design barriers. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  V. Pinn,et al.  NIH Policy on the Inclusion of Women and Minorities as Subjects in Clinical Research , 2002 .

[48]  C. Grady,et al.  What makes clinical research ethical? , 2000, JAMA.

[49]  E. Trimble,et al.  Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials. , 1996, Journal of the National Cancer Institute.

[50]  L. Minasian,et al.  Minority recruitment to the Selenium and Vitamin E Cancer Prevention Trial (SELECT) , 2005, Clinical trials.

[51]  M. Fouad,et al.  Statewide Tuskegee Alliance for clinical trials. A community coalition to enhance minority participation in medical research. , 2001, Cancer.

[52]  R E Lenhard,et al.  The impact of clinical trial protocols on patient care system , 1993, Cancer.

[53]  P. Philip,et al.  Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  M. Mayo,et al.  Participation of African Americans in a smoking cessation trial: a quantitative and qualitative study. , 2002, Journal of the National Medical Association.

[55]  W. McCaskill-Stevens,et al.  Recruiting minority cancer patients into cancer clinical trials: a pilot project involving the Eastern Cooperative Oncology Group and the National Medical Association. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  Joy H. Lewis,et al.  Participation of patients 65 years of age or older in cancer clinical trials. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  Tung T. Nguyen,et al.  Participation of Asian‐American women in cancer chemoprevention research , 2005, Cancer.

[58]  W. El-Sadr,et al.  The challenge of minority recruitment in clinical trials for AIDS. , 1992, JAMA.

[59]  Shari Bolen,et al.  Provider roles in the recruitment of underrepresented populations to cancer clinical trials , 2007, Cancer.

[60]  Jon D. Miller,et al.  Public attitudes toward participation in cancer clinical trials. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[61]  B. Smedley,et al.  The unequal burden of cancer : an assessment of NIH research and programs for ethnic minorities and the medically underserved , 1999 .

[62]  C. A. Aguilera,et al.  The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, II: characteristics of patients enrolled and not enrolled. COMS Report No. 17. , 2001, Archives of ophthalmology.

[63]  G. Guyatt,et al.  Grading quality of evidence and strength of recommendations , 2004, BMJ : British Medical Journal.

[64]  J. Crawford,et al.  Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials , 2002, Cancer.

[65]  J. Trauth,et al.  Factors affecting older african american women's decisions to join the PLCO Cancer Screening Trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[66]  M. Fouad,et al.  African-American attitudes regarding cancer clinical trials and research studies: results from focus group methodology. , 2000, Ethnicity & disease.

[67]  R. Chamberlain,et al.  Social factors affecting interest in participating in a prostate cancer chemoprevention trial. , 1999, Journal of cancer education : the official journal of the American Association for Cancer Education.

[68]  J. Ard,et al.  Perceptions of African-American culture and implications for clinical trial design. , 2005, Ethnicity & disease.

[69]  F. Barg,et al.  A Study on Recruitment of Black Americans Into Clinical Trials Through A Cultural Competence Lens , 2000, Cancer nursing.

[70]  Joanne M. Hall,et al.  Children in Research: The Experience of Ill Children and Adolescents , 2001 .

[71]  K. Mooney,et al.  Factors that influence Spanish‐ and English‐speaking participants' decision to enroll in cancer randomized clinical trials , 2006, Psycho-oncology.

[72]  M. Fouad,et al.  Statewide Tuskegee Alliance for clinical trials , 2001 .

[73]  B. Peterson,et al.  Barriers to the participation of African‐American patients with cancer in clinical trials , 2003, Cancer.

[74]  A. Neugut,et al.  Barriers to minority participation in breast carcinoma prevention trials , 2005, Cancer.

[75]  J. Ehman,et al.  Barriers to the participation of African-American patients with cancer in clinical trials : a pilot study , 2005 .

[76]  M. Johnson,et al.  Barriers to black women's participation in cancer clinical trials. , 1997, Journal of the National Medical Association.

[77]  L. Bernstein,et al.  Patterns of enrollment on cooperative group studies. An analysis of trends from the Los Angeles county cancer surveillance program , 1993, Cancer.

[78]  W. McCaskill-Stevens,et al.  Physician perspectives on increasing minorities in cancer clinical trials: an Eastern Cooperative Oncology Group (ECOG) Initiative. , 2000, Annals of epidemiology.

[79]  D. Gandara,et al.  Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[80]  L. Beckett,et al.  An Evaluation of Barriers to Accrual in the Era of Legislation Requiring Insurance Coverage of Cancer Clinical Trial Costs in California , 2004, Cancer journal.

[81]  E. Skinner,et al.  Randomized clinical trials of cancer treatment--a public opinion survey. , 1984, Clinical oncology.

[82]  M. Ruffin,et al.  Women's feedback on a chemopreventive trial for cervical dysplasia. , 2003, Applied nursing research : ANR.

[83]  H. Aaron.  Primary care physicians who treat blacks and whites. , 2004, The New England journal of medicine.

[84]  H. Cohen,et al.  Barriers to clinical trial participation by older women with breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[85]  H. Cohen,et al.  Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.